Spectral CT IDs heart plaque better than conventional
Researchers can for the first time visualize coronary artery plaques vulnerable to rupture using spectral CT, an innovation that will lead to better and earlier diagnosis of cardiovascular disease, according to researchers.
Researchers can for the first time visualize coronary artery plaques vulnerable to rupture using spectral CT, an innovation that will lead to better and earlier diagnosis of cardiovascular disease, according to researchers.
Ruptured atherosclerotic plaques are the cause of nearly 70% of heart attacks. High-density lipoproteins (HDL) gravitate to plaques vulnerable to rupture and remove them from the arterial wall. Researchers from Mount Sinai in New York inserted tiny gold particles into HDL and injected mice with them. Using a spectral CT scanner from Philips Medical Systems, the researchers were able to see the gold particles as the HDL targeted microphages, thus illuminating the location of the vulnerable plaques.
Conventional CT doesn’t provide enough contrast to differentiate types and density of tissue. Spectral CT shows the effect of gold particles while also distinguishing calcium deposits and contrast agents. Together, this information is used to identify stenoses, thus helping define both the severity of atherosclerosis and heart attack risk.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
